Results 31 to 40 of about 14,748 (188)

A case of arrhythmogenic right ventricular dysplasia/cardiomyopathy with pneumothorax and degloving injury of the right upper limb

open access: yesBLDE University Journal of Health Sciences, 2020
Arrhythmogenic right ventricular dysplasia / cardiomyopathy (ARVD / C) is a rare genetic cardiomyopathy characterized by fibro-fatty replacement primarily of the right ventricular myocytes,and can present as any of 'concealed' disease, 'overt arrhythmia'
Varun Suresh
doaj   +1 more source

Etiopathogenesis of arrhythmogenic right ventricular cardiomyopathy [PDF]

open access: yesJournal of Human Genetics, 2005
Arrhythmogenic right ventricular cardiomyopathy (ARVC) is characterised by progressive fibro-fatty replacement of right ventricular myocardium. Earlier studies described ARVC as non-inflammatory, non-coronary disorder associated with arrhythmias, heart failure and sudden death due to functional exclusion of the right ventricle.
Maithili V N, Dokuparti   +4 more
openaire   +2 more sources

Catheter Ablation of Ventricular Tachycardia in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia: A Sequential Approach

open access: yesJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2019
Background It has been suggested that endocardial and epicardial ablation of ventricular tachycardia (VT) improves outcome in arrhythmogenic right ventricular cardiomyopathy/dysplasia.
Shibu Mathew   +18 more
doaj   +1 more source

Physical exercise and arrhythmogenic right ventricular cardiomyopathy/dysplasia: An overview

open access: yesHeart Views, 2022
Arrhythmogenic right ventricular cardiomyopathy/dysplasia is inherited cardiomyopathy that has a propensity for ventricular arrhythmia, ventricular dysfunction, and sudden cardiac death.
Rasha Kaddoura, Hassan Al-Tamimi
doaj   +1 more source

Arrhythmogenic potential of cardiomyopathies

open access: yesМедицина неотложных состояний
The article presents a review of literary scientific sources from the MEDLINE database on PubMed, Web of Science, Scopus, and Google Scholar platforms, focusing on arrhythmia in patients with arrhythmogenic cardiomyopathy.
O.M. Kovalova   +5 more
doaj   +1 more source

Treatment of arrhythmogenic right ventricular cardiomyopathy (dysplasia) [PDF]

open access: yesКардіохірургія та інтервенційна кардіологія, 2016
Arrhythmogenic right ventricular cardiomyopathy (dysplasia) is an inheritable heart muscle disease predisposing to ventricular arrhythmias and increasing risk of sudden cardiac death.
M.Т. Vatutin   +5 more
doaj  

Left Ventricular Dysfunction in Arrhythmogenic Cardiomyopathy: Association With Exercise Exposure, Genetic Basis, and Prognosis

open access: yesJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2021
Background Arrhythmogenic cardiomyopathy (AC) is characterized by biventricular dysfunction, exercise intolerance, and high risk of ventricular tachyarrhythmias and sudden death.
Øyvind H. Lie   +8 more
doaj   +1 more source

Management of arrhythmogenic right ventricular cardiomyopathy

open access: yesHeart, 2023
Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a disease characterised by fibrofatty replacement of the ventricular myocardium due to specific mutations, leading to ventricular arrhythmias and sudden cardiac death. Treating this condition can be challenging due to progressive fibrosis, phenotypic variations and small patient cohorts limiting
Sayed Al-Aidarous   +3 more
openaire   +3 more sources

Disulfide Bond–Modified Proteomics Reveals the Effects of Riboflavin on Protein Folding Dynamics

open access: yesAnimal Research and One Health, EarlyView.
Riboflavin deficiency impairs oxidative protein folding, causing ER misfolded protein accumulation, CHOP activation, and apoptosis, revealing a role of riboflavin in proteostasis. ABSTRACT Riboflavin is a crucial micronutrient essential for maintaining cellular homeostasis, acting as an important precursor for flavoproteins that utilize flavin ...
Bo Zhang, Shuisheng Hou, Jing Tang
wiley   +1 more source

Cardiac remodelling in the era of the recommended four pillars heart failure medical therapy

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1029-1044, April 2025.
Abstract Cardiac remodelling is a key determinant of worse cardiovascular outcome in patients with heart failure (HF) and reduced ejection fraction (HFrEF). It affects both the left ventricle (LV) structure and function as well as the left atrium (LA) and the right ventricle (RV).
Giada Colombo   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy